Featuring perspectives from Prof John Seymour, including the following topics:
Safety of fixed-duration acalabrutinib/venetoclax for chronic lymphocytic leukemia (CLL) (0:00) Venetoclax re-treatment and ongoing trials with acalabrutinib/venetoclax for CLL (6:21) First-line treatment with sonrotoclax and zanubrutinib for CLL (13:10)Receive updates from Research To Practice | Oncology Videos for free, starting right now.
We can deliver them by email, via your phone or you can read them from a personalised news page on follow.it.
This way you won't miss any new article from Research To Practice | Oncology Videos. Unsubscribe at any time.
Site title: Research To Practice | Oncology Videos